Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contraindications/special warnings and precautions for use of contemporary oral antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Vavuranakis M, Davlouros P, Ntalas I, Angelidis C, Hahalis G, Triposkiadis F, Vardas P, Stefanadis C, Goudevenos JA; GRAPE Investigators. Alexopoulos D, et al. Among authors: angelidis c. Circ J. 2014;78(1):180-7. doi: 10.1253/circj.cj-13-0795. Epub 2013 Nov 2. Circ J. 2014. PMID: 24189502 Free article. Clinical Trial.
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
Alexopoulos D, Goudevenos JA, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Parissis H, Ntalas IV, Angelidis C, Petousis S, Vavuranakis M, Hahalis G, Stefanadis C; GRAPE Investigators. Alexopoulos D, et al. Among authors: angelidis c. Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15. Int J Cardiol. 2013. PMID: 23978364 Clinical Trial.
In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Angelidis C, Petousis S, Stakos D, Parissis H, Vavouranakis M, Davlouros P, Goudevenos J, Stefanadis C. Alexopoulos D, et al. Among authors: angelidis c. Am Heart J. 2014 Jan;167(1):68-76.e2. doi: 10.1016/j.ahj.2013.10.010. Epub 2013 Oct 22. Am Heart J. 2014. PMID: 24332144
Bivalirudin use and one-month outcome in the context of contemporary antiplatelet treatment: insights from the Greek Antiplatelet Registry.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Karayannis G, Angelidis C, Stavrou K, Vavuranakis M, Goudevenos JA, Stefanadis C; GRAPE Investigators. Alexopoulos D, et al. Among authors: angelidis c. Cardiovasc Ther. 2014 Jun;32(3):120-6. doi: 10.1111/1755-5922.12068. Cardiovasc Ther. 2014. PMID: 24512682 Free article.
Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study.
Alexopoulos D, Makris G, Xanthopoulou I, Patsilinakos S, Deftereos S, Gkizas V, Perperis A, Karanikas S, Angelidis C, Tsigkas G, Koutsogiannis N, Hahalis G, Davlouros P. Alexopoulos D, et al. Among authors: angelidis c. Circ Cardiovasc Interv. 2014 Apr;7(2):233-9. doi: 10.1161/CIRCINTERVENTIONS.113.001118. Epub 2014 Mar 25. Circ Cardiovasc Interv. 2014. PMID: 24668226 Clinical Trial.
In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE.
Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Karayannis G, Angelidis C, Stavrou K, Vavuranakis M, Goudevenos JA, Stefanadis C, Alexopoulos D. Xanthopoulou I, et al. Among authors: angelidis c. Int J Cardiol. 2014 Jun 1;174(1):160-2. doi: 10.1016/j.ijcard.2014.03.161. Epub 2014 Mar 28. Int J Cardiol. 2014. PMID: 24726352 No abstract available.
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, Sianos G, Goudevenos J, Alexopoulos D, Pyrgakis V, Cleman MW, Manolis AS, Tousoulis D, Lekakis J. Deftereos S, et al. Among authors: angelidis c. Circulation. 2015 Oct 13;132(15):1395-403. doi: 10.1161/CIRCULATIONAHA.115.017611. Epub 2015 Aug 11. Circulation. 2015. PMID: 26265659 Clinical Trial.
Effect of Angiotensin converting enzyme inhibitors on soluble tumor-necrosis-factor-related apoptosis-inducing ligand levels - association with neointimal hyperplasia in drug eluting stents.
Giannopoulos G, Panagopoulou V, Deftereos S, Angelidis C, Davlouros P, Synetos A, Toutouzas K, Alexopoulos D, Cleman MW, Tousoulis D. Giannopoulos G, et al. Among authors: angelidis c. J Interv Cardiol. 2014 Dec;27(6):582-90. doi: 10.1111/joic.12153. Epub 2014 Sep 9. J Interv Cardiol. 2014. PMID: 25203156 Free article.
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Deftereos SG, et al. Among authors: angelidis c. JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136. JAMA Netw Open. 2020. PMID: 32579195 Free PMC article. Clinical Trial.
Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
Alexopoulos D, Gkizas V, Patsilinakos S, Xanthopoulou I, Angelidis C, Anthopoulos P, Makris G, Perperis A, Karanikas S, Koutsogiannis N, Davlouros P, Deftereos S, Chiladakis J, Hahalis G. Alexopoulos D, et al. Among authors: angelidis c. J Am Coll Cardiol. 2013 Sep 3;62(10):940-1. doi: 10.1016/j.jacc.2013.05.021. Epub 2013 Jun 7. J Am Coll Cardiol. 2013. PMID: 23747780 Free article. Clinical Trial. No abstract available.
69 results